Healthtech AI CEO Circle

AI can make the product stronger. It can also make the market harder to convince.

A private, member-led peer circle for healthtech CEOs bringing AI-enabled products to market, where buyers ask harder questions, investors scrutinize the claim, and evidence, regulatory, privacy, security, clinical, and workflow expectations rise.

Founding circle forming. 6 to 8 CEOs · 3 monthly 90-minute sessions · confidential · virtual. How the circles work.

Who it is for

For CEOs and founders of AI-enabled healthtech, digital health, medtech, diagnostics, SaMD, clinical workflow, payer and provider platform, and tech-enabled healthcare product companies.

  • Which AI use cases are worth building around?
  • Who is the first buyer that can actually adopt?
  • What can we responsibly claim?
  • What evidence will buyers, investors, or regulators expect?
  • How do we avoid pilots that do not convert?
  • What should we build, buy, or partner around?
  • How do we make the product credible to enterprise buyers?
  • What operating model do we need before scaling AI product decisions?

This is not a generic founder group. It is a confidential CEO room for leaders building AI-enabled health products that need to survive buyer, investor, enterprise, and regulatory scrutiny.

The CEO problem

AI changes the product story. It also changes what the market needs to believe.

Most healthtech CEOs are under pressure to make AI part of the roadmap, the pitch, or the product. The CEO-level questions are not just technical.

Is this AI use case valuable enough to matter?
Does it change the buyer or the workflow?
Can we support the claim?
Will the evidence be credible?
Will enterprise review slow the deal?
Does this create regulatory, privacy, security, or clinical risk?
Will investors believe the AI story?
Can the team operate what we are promising?

The 3-month rhythm

The agenda is member-led, but the conversation usually moves through three levels.

01
Which AI bets are worth making?
Which use cases have enough buyer urgency, workflow value, data readiness, evidence path, commercial potential, and defensibility to deserve focus?
02
What will the market believe?
What needs to be true across claims, evidence, buyer confidence, enterprise readiness, investor scrutiny, regulatory posture, and adoption risk?
03
What operating model makes this scalable?
What decision rights, review cadence, governance, monitoring, and next-90-day priorities move you from AI demo or roadmap item to credible adoption?

Topics members may bring

Members shape the agenda based on the decisions they are actively facing.

How the circle works

The format, curation, what members get, how this differs from direct advisory, and the full FAQ live on the CEO Circles overview.

See how the circles work

Request an invitation.

The Healthtech AI CEO Circle is forming its founding group. If this is the room you need, request an invitation or ask about fit.